Summary of Purpose
Sesame is a European, multi-center, single arm, prospective, observational registry. Sesame aims to demonstrate that use of SOFIA™/SOFIA™ PLUS catheter for direct aspiration as a first line treatment technique is fast, safe and effective in patients suffering an Acute Ischemic Stroke when assessed at 24 hours, discharge and 90 days after treatment. 250 patients will be enrolled. All patients will be followed for...Read More →
The following dates are available for this trial. Trial information last updated on 24 January 2018.
|1 Oct 2017||16 Jan 2018||28 Feb 2020||30 May 2020||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
Sponsors See All